MiniMed Group, Inc. Common Stock
NASDAQ:MMEDMedical - Care Facilities
Healthcare
$16.99 +2.63%
+$0.40 today
- Market cap
- $4.78B
- Beta
- -3.63
- P/E (TTM)
- -14.2
- EPS (TTM)
- -$1.91
52W Low $10.65High $20.48
Volume 4.70M
Average 0.95M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$197.00M
FY 2025 · Annual
Investing Cash Flow
-$233.00M
FY 2025 · Annual
Financing Cash Flow
$716.00M
FY 2025 · Annual
+7060.0% YoYCash Flow Statement
USD
Metric | FY2022 Apr 2023 | FY2023 Apr 2024 | FY2024 Apr 2025 | FY2025 Apr 2026 |
|---|---|---|---|---|
| Net Income | (92M) | (107M) | (198M) | (317M) |
| Depreciation & Amortization | 115M | 129M | 143M | 156M |
| Deferred Income Tax | (11M) | 3M | (2M) | (54M) |
| Stock-Based Compensation | 35M | 38M | 41M | 46M |
| Change in Working Capital | (90M) | (74M) | 122M | (166M) |
| Accounts Receivables | (70M) | (105M) | (66M) | (538M) |
| Inventory | (28M) | 5M | (19M) | (29M) |
| Accounts Payables | 14M | (4M) | 191M | 41M |
| Other Working Capital | (6M) | 30M | 16M | 360M |
| Other Non-Cash Items | 37M | 52M | 34M | 138M |
| Operating Cash Flow | (6M) | 41M | 140M | (197M) |
| Capital Expenditures | (167M) | (148M) | (193M) | (223M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 |
| Purchases of Investments | (13M) | (5M) | 0 | 0 |
| Sales of Investments | 0 | 11M | 0 | 0 |
| Other Investing Activities | 0 | (15M) | 0 | (10M) |
| Investing Cash Flow | (180M) | (157M) | (193M) | (233M) |
| Debt Repayment | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 538M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | 185M | 112M | 10M | 178M |
| Financing Cash Flow | 185M | 112M | 10M | 716M |
| Effect of Forex Changes | 0 | 0 | 0 | 1M |
| Net Change in Cash | (2M) | (4M) | (43M) | 287M |
| Free Cash Flow | (173M) | (107M) | (53M) | (420M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$317.0M
+ D&A$156.0M
+ Stock-Based Comp$46.0M
- Deferred Tax-$54.0M
- Working Capital-$166.0M
+ Other Non-Cash$138.0M
= Operating Cash Flow-$197.0M
- Capex-$223.0M
= Free Cash Flow-$420.0M
Analysis
FY2025 free cash flow is -$420.0M. FCF conversion is 132.5% of net income. Operating cash flow was -$197.0M, with capex of -$223.0M. The largest bridge item is Capex at -$223.0M.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G | SC 13G filing | Nov 6, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 30, 2026 | |
| SC 13G | SC 13G filing | Oct 22, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 19, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 19, 2026 |
Does MMED generate free cash flow?
MiniMed Group, Inc. Common Stock (MMED) generated -$420.00M of free cash flow in fiscal 2025.
How much operating cash flow does MMED produce?
Operating cash flow was -$197.00M, before capital expenditures of $223.00M.
Continue the stock analysis
Jump to another research area for this company.